Assyro AI

Orange Book product · Brand (NDA)

ESOMEPRAZOLE MAGNESIUM

ESOMEPRAZOLE MAGNESIUM

Brand (NDA)NDA 214278DISCN DEXCEL

At a glance

Oct 20, 2020

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 20, 2020

    5 yr 9 mo ago

  2. Today

  3. Patent 10076494 expires

    Listed drug product patent expiration.

    Dec 08, 2036

    in 10 yr 8 mo

  4. Patent 10835488 expires

    Listed drug product patent expiration.

    Dec 08, 2036

    in 10 yr 8 mo

Pharmaceutical detail

Active ingredient

ESOMEPRAZOLE MAGNESIUM

Strength

EQ 20MG BASE

Dosage form

TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE

Route

ORAL

TE code

Not listed

Application

NDA 214278

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10076494Dec 08, 2036in 10 yr 8 mo
Product
10835488Dec 08, 2036in 10 yr 8 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.